Incorporated in 2012, Eboo Pharmaceuticals inc (EPI) is an emerging pharmaceutical company with late, preclinical-stage compounds for Parkinson’s Disease, Major Depression and Reperfusion Injury related to Myocardial Ischemia.
- Eboo Pharmaceuticals Inc to Present at Biotech Showcase™ 2014
- Outstanding rodent results secure continued funding from The Michael J. Fox Foundation for Parkinson’s Research
- Eboo Pharmaceuticals to present at SEBIO 2013, Richmond, VA
- Eboo Pharmaceuticals Inc. Announces Award from The Michael J. Fox Foundation for Early Development Research for Parkinson’s Disease
- EPI to present at NCBC Emerging Companies Preview